MedTrace Logo

Moderate Intensity vs High Intensity Interval Training in Women With Heart Failure

NCT07662876 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-06-23

No results posted yet for this study

Summary

* To determine the effects of moderate intensity exercise vs high intensity interval training on functional capacity in women with heart failure
* To determine the effects of moderate intensity exercise vs high intensity interval training on quality of life in women with heart failure

Conditions

Interventions

OTHER

moderate-intensity aerobic training

Group A will undergo a moderate-intensity aerobic training program as part of a structured cardiac rehabilitation protocol. The program will be supervised sessions, conducted three times per week for 12 weeks. Each session will include approximately 30 minutes of aerobic exercise performed on a bicycle ergometer at an intensity of 60% of heart rate reserve (HRR)

OTHER

High-intensity interval training

Group B will perform a high-intensity interval training (HIIT) program designed according to established cardiac rehabilitation protocols. Bicycle ergometer will be used, in which each session will begin with a 10-minute warm-up (lower limb large muscle stretches), followed by intervals performed at 80% of heart rate reserve (HRR) for 3 min, alternating with recovery periods at low intensity 40% of HRR for 3 min. The total exercise duration will be approximately 30 minutes per session, conducted three times weekly for 12 weeks under supervision. Participants will be encouraged to maintain self-directed exercise after the intervention period

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Muhammad iqbal Tariq, PhD* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07662876 on ClinicalTrials.gov